Atyr Pharma Inc

-0.20 (-4.40%)
Debt Financing / Related, Earnings Announcements

ATyr Pharma Reports Q3 2020 Results

Published: 11/12/2020 21:43 GMT
aTyr Pharma Inc (LIFE) - Atyr Pharma Announces Third Quarter 2020 Results and Provides Corporate Update.
Atyr Pharma Inc - As of September 30, 2020, Atyr Had $36.1 Million in Cash, Cash Equivalents and Investments.
Atyr Pharma Inc - on November 3, 2020, Atyr Fully Repaid Its Term Loans and Retired Its Debt.
Atyr Pharma Inc - Qtrly Loss per Share $0.68.
Revenue is expected to be $0.13 Million
Adjusted EPS is expected to be -$0.80

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.92

More details on our Analysts Page.